Phase
Condition
Manic Disorders
Williams Syndrome
Treatment
Buccal midazolam
Sublingual Dexmedetomidine
Oral lorazepam
Clinical Study ID
Ages 18-64 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
18-64 years
Agitation with the need for tranquillization in inpatient psychiatric settingsincluding psychiatric emergency rooms
Total score of ≥14 on the PANSS Excited Component (PEC)
A score ≥4 on at least 1 of the 5 items of the PEC
Informed consent obtained prior to the occurrence of the emergency
Exclusion
Exclusion Criteria:
Involuntary psychiatric admission according to the Danish Mental Health Act
Female patients who are breastfeeding
Female patients aged <50 years and unable to perform a negative urine screen forpregnancy and not using safe contraceptives
Body weight <50 kg
Extreme obesity defined as estimated BMI≥ 40 kg/m2
Clinical situations where acute administration of an antipsychotic is preferred totreat acute agitation (in the opinion of the investigator)
The patient deemed unwilling or unable to cooperate with study procedures (in theopinion of the investigator)
Insufficient language skills that interfere with reading, writing, and providingwritten informed consent in Danish or other available languages (in the opinion ofthe investigator)
Clinical suspicion of contraindications for one of the treatment arms
Use of benzodiazepines, other sedatives, or antipsychotic drugs in addition to usualtreatment (i.e., additional PN sedative prescriptions) in the 4 hours before studytreatment
Known allergy to any of the study medications
Study Design
Study Description
Connect with a study center
Mental Health Center Copenhagen, Bispebjerg
Copenhagen N, 2400
DenmarkActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.